| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | $3.11M | $12.29M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $14.54M | $14.38M | $17.11M | $17.88M | $18.99M |
| SG&A | $11.77M | $10.22M | $11.77M | $13.87M | $14.70M |
| Operating Income | -$26.31M | -$24.60M | -$28.88M | -$28.64M | -$21.40M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | – | – | – | – |
| Net Income | -$25.97M | -$24.13M | -$17.41M | $8.03M | -$28.46M |
| EPS (basic) | -87.2700 | -87.3800 | -1.4200 | 1.5700 | -6.0700 |
| EPS (diluted) | -87.2700 | -87.3800 | -1.4200 | 1.5700 | -6.0700 |
| Shares (diluted) | $315.54K | $276.14K | $12.23M | $5.10M | $4.69M |